StemCyte Inc. is a world leader in cord blood banking.
StemCyte India started its operations in 2010, as a joint venture between StemCyte Inc. (USA), Apollo Hospitals & Cadila Pharmaceuticals Ltd. StemCyte India Therapeutics Pvt Ltd has signed an MOU in Vibrant Gujarat Summit -2007. StemCyte India adopts a unique “Hybrid+ Model” which involves Public & Private Cord Blood Banking, Clinical Trials & Therapeutics Applications.
StemCyte is world’s leader in Umbilical Cord Blood Transplantation & has facilitated 2200+ transplants across 350+ transplant centers in more than 40 countries across 6 Continents. StemCyte uses Patented Plasma Depletion (PD) Technology which is the best in class technology. StemCyte India is the only cord blood banking company with 'FACT' accreditation. StemCyte uses high quality collection bag to ensure max collection of cord blood, further which Cord Blood is transported in our specially designed advance collection kit box to our fully equipped Lab at Gandhinagar.